Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04629053
Other study ID # BAC20003
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 21, 2022
Est. completion date December 1, 2024

Study information

Verified date May 2024
Source University of Oxford
Contact Yoel Lubell, Prof.
Phone +66-857201350
Email yoel@tropmedres.ac
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This prospective multi-site observational study aims to describe causes and clinical outcomes of acute febrile illness as well as host biomarkers in patients aged >28 days residing in rural areas in Laos, Myanmar, Thailand, the Thai-Myanmar border region, and Bangladesh and presenting with acute febrile illnesses (≤ 14 days duration) to participating health facilities. This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z


Description:

The majority of people in low- and middle-income countries (LMICs) in South and Southeast Asia live in rural areas. These people are some of the poorest in the region and the exact health issues which concern them have not been well defined, in that they have not been fully studied. Despite this lack of data, there are indications that disease of an infectious aetiology, 'febrile illness,' in particular in the tropics, still accounts for significant morbidity and mortality. This is in contrast to higher-income countries. The South and Southeast Asian Community-based Trials Network in Rural Febrile Illness project (SEACTN RFI) aims to better understand and quantify the burden of febrile illness, the aetiological causes and the manner in which it affects the people of the area, all on a scale which has not been attempted before. It will collect information to help better understand and predict these outcomes based on a multitude of factors, which will form the basis for interventions within the network in the future. The initial study will be observational, as the current understanding of the local health issues and the health systems in these areas is insufficient to know how best to intervene. In a separate work package, Work Package A (WP-A), the investigators will be collecting data from within the participating SEACTN communities through village health workers (VHWs) and local health facilities on the incidence, causes and outcomes of febrile illness in these areas. In Work Package B (WP-B) will recruit patients seeking care at higher level facilities than the WP-A VHWs and health centres. These patients are likely to be more severely ill, in order to obtain a more thorough understanding of the causes and burden of febrile illness in these areas. A broader range of specimens, including venous blood samples and respiratory specimens will be collected. In-depth diagnostic testing including blood cultures, serological assays, pathogen molecular diagnostics, host biomarker assays, and validation of pathogen-blind next generation sequencing approaches will be conducted. The data from WP-A gathered in the community complemented by the WP-B data from higher level health facilities in the same regions will provide a rich understanding of the causes, incidence and outcomes of febrile illness in these areas. These data will be analysed using advanced statistical methodology to create electronic decision-support tools (eDSTs) to aid VHWs in their assessment, triage and treatment of patients. These and other relevant interventions will later be trialled across the SEACTN villages.


Recruitment information / eligibility

Status Recruiting
Enrollment 7200
Est. completion date December 1, 2024
Est. primary completion date December 1, 2024
Accepts healthy volunteers No
Gender All
Age group 29 Days and older
Eligibility Inclusion Criteria: 1. The patient and/or where relevant their parent/guardian/caretaker is willing and able to give informed consent /assent for participation in the study; 2. Aged > 28 days (day of birth = Day 1); 3. Axillary temperature at presentation (= 37.5°C (99.5°F) OR < 35.5°C (95.9°F)) and no more likely cause than sepsis for hypothermia OR History of fever in the 24 hours prior to presentation; 4. Onset of illness = 14 days Exclusion Criteria: 1. Accident or trauma is the cause for the patient's presentation; 2. Presentation = 3 days after routine immunisations 3. Is currently under follow-up or has been afebrile for less than 72 hours after completion of a follow-up period. 4. The treating healthcare worker's decision is to send the patient home following initial assessment.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Bangladesh Building Resources Across Communities (BRAC) Dhaka
Lao People's Democratic Republic Laos-Oxford-Mahosot Wellcome Trust Research Unit Vientiane
Thailand Chiangrai Clinical Research Unit (CCRU) Chiang Rai
Thailand Shoklo Malaria Research Unit Mae Sot Tak

Sponsors (6)

Lead Sponsor Collaborator
University of Oxford Building Resources Across Communities (BRAC), Bangladesh, Chiang Rai Clinical Research Unit (CCRU), Thailand, Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Mahidol Oxford Tropical Medicine Research Unit, Shoklo Malaria Research Unit (SMRU)

Countries where clinical trial is conducted

Bangladesh,  Lao People's Democratic Republic,  Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of pathogens Prevalence of a range of pathogens identified from febrile patients, analysed by region and participant age group Samples collected over approximately 1 month
Secondary Recovery status Recovery status e.g. full recovery, partial recovery, deterioration, and death at specified time points up to 28 days from enrolment Approximately 1 month
Secondary The association between host biomarkers and other predictors with aetiological diagnoses and clinical outcomes The area under the curve, sensitivity and specificity of host biomarkers and other predictors to identify bacterial infections and to predict severe outcomes. Samples collected over approximately 1 month
See also
  Status Clinical Trial Phase
Completed NCT03943654 - Improving Nighttime Access to Care and Treatment (Part 2)
Completed NCT04299412 - Diagnostic Accuracy of the DPP II Assay
Completed NCT04299607 - Evaluation of the DPP II Assay in Laos
Recruiting NCT05050825 - Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal N/A
Recruiting NCT04878549 - Transcriptomic Responses for the Identification of Pathogens
Completed NCT04268732 - Acute Undifferentiated Fever in Ethiopia
Completed NCT02763462 - The Etiology of Acute Febrile Illness Requiring Hospitalization
Recruiting NCT05292508 - Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test N/A
Completed NCT01403350 - Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan Phase 4
Completed NCT02225769 - Electronic Algorithms Based on Host Biomarkers to Manage Febrile Children N/A
Completed NCT04081051 - Advancing Access to Diagnostic Innovation Essential for UHC and AMR Prevention N/A